Simplex Trading’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-20,259
| Closed | -$5K | – | 11019 |
|
|
2022
Q3 | $5K | Buy |
20,259
+15,937
| +369% | +$6.96K | ﹤0.01% | 8861 |
|
|
2022
Q2 | $3K | Buy |
+4,322
| New | +$3.85K | ﹤0.01% | 9267 |
|
|
2022
Q1 | – | Sell |
-4,586
| Closed | -$8.33K | – | 11805 |
|
|
2021
Q4 | $8K | Buy |
+4,586
| New | +$11K | ﹤0.01% | 9262 |
|
|
2020
Q4 | – | Sell |
-19,796
| Closed | -$97.2K | – | 9332 |
|
|
2020
Q3 | $96K | Buy |
+19,796
| New | +$108K | ﹤0.01% | 4951 |
|
|
2019
Q2 | – | Sell |
-1,580
| Closed | -$6.47K | – | 8064 |
|
|
2019
Q1 | $6K | Buy |
1,580
+516
| +48% | +$1.8K | ﹤0.01% | 6437 |
|
|
2018
Q4 | $2K | Buy |
1,064
+830
| +355% | +$4.86K | ﹤0.01% | 6648 |
|
|
2018
Q3 | $1K | Sell |
234
-290
| -55% | -$1.27K | ﹤0.01% | 7256 |
|
|
2018
Q2 | $1K | Buy |
+524
| New | +$2.42K | ﹤0.01% | 7231 |
|
|
2018
Q1 | – | Sell |
-957
| Closed | -$4.02K | – | 7124 |
|
|
2017
Q4 | $3K | Buy |
+957
| New | +$3.61K | ﹤0.01% | 5031 |
|
|
2017
Q2 | – | Sell |
-15
| Closed | -$84 | – | 7030 |
|
|
2017
Q1 | $0 | Buy |
+15
| New | +$117 | ﹤0.01% | 6999 |
|
Simplex Trading's AGTC Position: Q4 2022 in Review
Simplex Trading sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 20,259 shares — an estimated $5K sold.
Simplex Trading first reported a position in AGTC in Q1 2017 and held it in 10 quarters. The position peaked at $96K in Q3 2020. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Simplex Trading reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Simplex Trading sold 20,259 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $5K.
- Simplex Trading first reported a position in Applied Genetic Technologies Corporation in Q1 2017 and held it in 10 quarters.
- Simplex Trading's Applied Genetic Technologies Corporation position peaked at $96K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.